Wake Forest Baptist Health — Winston-Salem, North Carolina

Public research footprint of Wake Forest Baptist Health, compiled from the ClinicalTrials.gov public registry.

357

Registered studies

Active

Recruiting now

195

Completed

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recently updated registry entries

NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT03907488 — Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in… (Active Not Recruiting)
NCT03803774 — Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Wake Forest Baptist Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.